DK549188A - Lymfocythaemmende hla-peptider - Google Patents

Lymfocythaemmende hla-peptider

Info

Publication number
DK549188A
DK549188A DK549188A DK549188A DK549188A DK 549188 A DK549188 A DK 549188A DK 549188 A DK549188 A DK 549188A DK 549188 A DK549188 A DK 549188A DK 549188 A DK549188 A DK 549188A
Authority
DK
Denmark
Prior art keywords
ctl
peptides
hla peptides
alpha
lymphocyte inhibitor
Prior art date
Application number
DK549188A
Other languages
Danish (da)
English (en)
Other versions
DK549188D0 (da
Inventor
Alan M Krensky
Peter Parham
Carol Clayberger
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK549188D0 publication Critical patent/DK549188D0/da
Publication of DK549188A publication Critical patent/DK549188A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK549188A 1987-01-30 1988-09-30 Lymfocythaemmende hla-peptider DK549188A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US884687A 1987-01-30 1987-01-30
US13854787A 1987-12-24 1987-12-24
PCT/US1988/000245 WO1988005784A1 (en) 1987-01-30 1988-01-27 Lymphocyte inhibition by hla peptides

Publications (2)

Publication Number Publication Date
DK549188D0 DK549188D0 (da) 1988-09-30
DK549188A true DK549188A (da) 1988-11-30

Family

ID=26678694

Family Applications (1)

Application Number Title Priority Date Filing Date
DK549188A DK549188A (da) 1987-01-30 1988-09-30 Lymfocythaemmende hla-peptider

Country Status (7)

Country Link
EP (1) EP0365525B1 (de)
AT (1) ATE126237T1 (de)
AU (1) AU619458B2 (de)
CA (1) CA1339185C (de)
DE (1) DE3854300T2 (de)
DK (1) DK549188A (de)
WO (1) WO1988005784A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US7011834B1 (en) 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
EP0459978B1 (de) * 1989-03-03 1997-07-16 The Regents Of The University Of California Klasse i-mhc-modulation von oberflächenrezeptoraktivität
DE4143467C2 (de) * 1991-05-17 1995-02-09 Max Planck Gesellschaft Peptidmotiv und dessen Verwendung
JP3345419B2 (ja) * 1991-11-08 2002-11-18 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ Ｃｄ８結合ドメイン・ペプチド
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
CA2142007C (en) * 1992-08-11 2007-10-30 Robert Glen Urban Immunomodulatory peptides
DE4238416A1 (de) * 1992-11-13 1994-05-19 Max Planck Gesellschaft Bestimmung von Peptidmotiven auf MHC-Molekülen
EP0684837A1 (de) * 1993-02-17 1995-12-06 Immune Network Research, Ltd. Methode zum modifizieren des t lymphocyten repertoires des immunsystems
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US5753625A (en) * 1995-05-12 1998-05-19 Sangstat Medical Corporation Treatment for inhibiting the progression of autoimmune disease
WO1997008328A1 (en) * 1995-08-30 1997-03-06 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Selective elimination of t cells that recognize specific preselected targets
US6436903B1 (en) 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
AU3209897A (en) * 1996-05-24 1997-12-09 Board Of Trustees Of The Leland Stanford Junior University Immunomodulating dimers
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
BR9808529B1 (pt) 1997-04-11 2010-10-05 oligopeptìdeo.
US7094413B2 (en) 2002-01-24 2006-08-22 Sangstat Medical Corporation Combined therapy for treatment of HIV infection
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection

Also Published As

Publication number Publication date
AU1342388A (en) 1988-08-24
DE3854300D1 (de) 1995-09-14
AU619458B2 (en) 1992-01-30
DK549188D0 (da) 1988-09-30
EP0365525A4 (en) 1990-12-12
EP0365525B1 (de) 1995-08-09
WO1988005784A1 (en) 1988-08-11
ATE126237T1 (de) 1995-08-15
EP0365525A1 (de) 1990-05-02
CA1339185C (en) 1997-07-29
DE3854300T2 (de) 1996-01-11

Similar Documents

Publication Publication Date Title
DK549188D0 (da) Lymfocythaemmende hla-peptider
ES2128362T3 (es) Fragmentos de proteinas de prion.
ES2056817T3 (es) Transformacion de trichoderma.
ES2150949T3 (es) Regulacion de la actividad de linfocitos con la ayuda de peptidos hla.
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
DK0643767T3 (da) Osteogene peptider
ATE295416T1 (de) Humanisiertes grünes-fluoreszenzprotein und methoden
DK0503648T3 (da) CD2-bindingsdomæne af lymfocytfunktion-associeret antigen 3
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
FI990875A0 (fi) CD4-spesifinen yhdistelmävasta-aine
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
DK0668772T3 (da) Specifik immunsystemmodulering
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
DE69434384D1 (de) Metalkomplexbildner
JPS6456697A (en) Viii factor bonded domain of von willebrand's factor
ES2186717T3 (es) Regulacion de la actividad de los linfocitos t citotoxicos ("ctl") mediante peptidos de la clase i del mhc.
DE69330352D1 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DK0625157T3 (da) Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf
ATE139259T1 (de) Selbstantigen der primären lebercirrhose
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
ES2145061T3 (es) Diagnostico y terapia a base de peptidos para el tratamiento de las espondiloartropatias.
IT1262898B (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk
DK0597043T3 (da) Porcine adipocytantigener og deres anvendelse til immunologisk bekæmpelse af fedt

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment